PENNSYLVANIA, February 3 - PRINTER'S NO. 1364

THE GENERAL ASSEMBLY OF PENNSYLVANIA

SENATE BILL

No.

1041

Session of

2022

INTRODUCED BY YAW, MARTIN, BARTOLOTTA, J. WARD, MENSCH, STEFANO,

BROOKS, PITTMAN AND VOGEL, FEBRUARY 3, 2022

REFERRED TO JUDICIARY, FEBRUARY 3, 2022

AN ACT

Amending the act of April 14, 1972 (P.L.233, No.64), entitled

"An act relating to the manufacture, sale and possession of

controlled substances, other drugs, devices and cosmetics;

conferring powers on the courts and the secretary and

Department of Health, and a newly created Pennsylvania Drug,

Device and Cosmetic Board; establishing schedules of

controlled substances; providing penalties; requiring

registration of persons engaged in the drug trade and for the

revocation or suspension of certain licenses and

registrations; and repealing an act," further providing for

drug overdose medication.

The General Assembly of the Commonwealth of Pennsylvania

hereby enacts as follows:

Section 1. Section 13.8 of the act of April 14, 1972

(P.L.233, No.64), known as The Controlled Substance, Drug,

Device and Cosmetic Act, is amended to read:

Section 13.8. Drug Overdose Medication.--(a) The

department, in carrying out its duties under 28 Pa. Code Ch.

1023 (relating to personnel), shall have the following duties:

(1) By December 31, [2014] 2022, amend the prehospital

practitioner scope of practice of emergency medical services

providers to include the administration of [naloxone] a drug or

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22